This study is in progress, not accepting new patients
Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at UCSD
- Dates
- study startedcompletion around
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Alfasigma S.p.A.
- ID
- NCT03025308
- Phase
- Phase 3 research study
- Study Type
- Interventional
- Participants
- About 2731 people participating
- Last Updated